Review



hcc1806  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    ATCC hcc1806
    Hcc1806, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 962 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1806/product/ATCC
    Average 97 stars, based on 962 article reviews
    hcc1806 - by Bioz Stars, 2026-06
    97/100 stars

    Images



    Similar Products

    97
    ATCC hcc1806
    Hcc1806, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1806/product/ATCC
    Average 97 stars, based on 1 article reviews
    hcc1806 - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    ovcar3  (ATCC)
    97
    ATCC ovcar3
    Ovcar3, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ovcar3/product/ATCC
    Average 97 stars, based on 1 article reviews
    ovcar3 - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    86
    Procell Inc hcc1806
    GLINT visualization of glycoRNA content changes during breast cancer malignant transformation. ( A–E ) Confocal images and single-cell fluorescence histograms of MCF-10A, MCF-7, BT474, SK-BR-3, MDA-MB-361, BT549 HS578t, MDA-MB-436, <t>HCC1806,</t> and MDA-MB-231 cells obtained via GLINT combined with T RNA-U1 , T RNA-U3 , T RNA-U35a , T RNA-Y5 , T RNA-U8 .
    Hcc1806, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1806/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    hcc1806 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    97
    ATCC hcc1806 cells
    GLINT visualization of glycoRNA content changes during breast cancer malignant transformation. ( A–E ) Confocal images and single-cell fluorescence histograms of MCF-10A, MCF-7, BT474, SK-BR-3, MDA-MB-361, BT549 HS578t, MDA-MB-436, <t>HCC1806,</t> and MDA-MB-231 cells obtained via GLINT combined with T RNA-U1 , T RNA-U3 , T RNA-U35a , T RNA-Y5 , T RNA-U8 .
    Hcc1806 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1806 cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    hcc1806 cells - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    99
    ATCC hcc1806 atcc crl
    GLINT visualization of glycoRNA content changes during breast cancer malignant transformation. ( A–E ) Confocal images and single-cell fluorescence histograms of MCF-10A, MCF-7, BT474, SK-BR-3, MDA-MB-361, BT549 HS578t, MDA-MB-436, <t>HCC1806,</t> and MDA-MB-231 cells obtained via GLINT combined with T RNA-U1 , T RNA-U3 , T RNA-U35a , T RNA-Y5 , T RNA-U8 .
    Hcc1806 Atcc Crl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1806 atcc crl/product/ATCC
    Average 99 stars, based on 1 article reviews
    hcc1806 atcc crl - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    97
    ATCC triple negative breast cancer cell line hcc1806
    Generation of PCDHGC3 knockout in breast cancer and melanoma cell lines. Western blot analysis of wild type (WT), control (C; transfected with the PCDH2 HDR Plasmid (h2) containing a puromycin resistance gene) and knockout (KO) <t>HCC1806</t> breast cancer cell line ( a ) and A2058 melanoma cell line ( b ). β-Actin served as an endogenous control.
    Triple Negative Breast Cancer Cell Line Hcc1806, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/triple negative breast cancer cell line hcc1806/product/ATCC
    Average 97 stars, based on 1 article reviews
    triple negative breast cancer cell line hcc1806 - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    Image Search Results


    GLINT visualization of glycoRNA content changes during breast cancer malignant transformation. ( A–E ) Confocal images and single-cell fluorescence histograms of MCF-10A, MCF-7, BT474, SK-BR-3, MDA-MB-361, BT549 HS578t, MDA-MB-436, HCC1806, and MDA-MB-231 cells obtained via GLINT combined with T RNA-U1 , T RNA-U3 , T RNA-U35a , T RNA-Y5 , T RNA-U8 .

    Journal: Nucleic Acids Research

    Article Title: In situ tracking of glycoRNAs on single-cell surface to reveal RNA heterogeneity and transport mechanism

    doi: 10.1093/nar/gkag362

    Figure Lengend Snippet: GLINT visualization of glycoRNA content changes during breast cancer malignant transformation. ( A–E ) Confocal images and single-cell fluorescence histograms of MCF-10A, MCF-7, BT474, SK-BR-3, MDA-MB-361, BT549 HS578t, MDA-MB-436, HCC1806, and MDA-MB-231 cells obtained via GLINT combined with T RNA-U1 , T RNA-U3 , T RNA-U35a , T RNA-Y5 , T RNA-U8 .

    Article Snippet: MCF-7cells were obtained from China Center for Type Culture Collection (CTCC), while MCF-10A, SK-BR-3, MDA-MB-231, BT549, Hs578T, HCC1806, MDA-MB-361, and MDA-MB-436 cells were purchased from Procell.

    Techniques: Transformation Assay, Single Cell, Fluorescence

    Generation of PCDHGC3 knockout in breast cancer and melanoma cell lines. Western blot analysis of wild type (WT), control (C; transfected with the PCDH2 HDR Plasmid (h2) containing a puromycin resistance gene) and knockout (KO) HCC1806 breast cancer cell line ( a ) and A2058 melanoma cell line ( b ). β-Actin served as an endogenous control.

    Journal: NeuroSci

    Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells

    doi: 10.3390/neurosci7020047

    Figure Lengend Snippet: Generation of PCDHGC3 knockout in breast cancer and melanoma cell lines. Western blot analysis of wild type (WT), control (C; transfected with the PCDH2 HDR Plasmid (h2) containing a puromycin resistance gene) and knockout (KO) HCC1806 breast cancer cell line ( a ) and A2058 melanoma cell line ( b ). β-Actin served as an endogenous control.

    Article Snippet: Triple-negative breast cancer cell line HCC1806 (CRL-2335, ATCC, Manassas, VA, USA) was cultured in RPMI medium (R7509-500ML, Sigma-Aldrich, St. Louis, MO, USA) containing 10% FCS, L-glutamine and penicillin/streptomycin.

    Techniques: Knock-Out, Western Blot, Control, Transfection, Plasmid Preparation

    Cell proliferation assay in control and PCDHGC3 knockout cells. Proliferation rate of control and PCDHGC3 knockout (KO) HCC1806 breast cancer cells ( a ) and of control and PCDHGC3 KO A2058 melanoma cells ( b ). **** = p < 0.0001, unpaired t test.

    Journal: NeuroSci

    Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells

    doi: 10.3390/neurosci7020047

    Figure Lengend Snippet: Cell proliferation assay in control and PCDHGC3 knockout cells. Proliferation rate of control and PCDHGC3 knockout (KO) HCC1806 breast cancer cells ( a ) and of control and PCDHGC3 KO A2058 melanoma cells ( b ). **** = p < 0.0001, unpaired t test.

    Article Snippet: Triple-negative breast cancer cell line HCC1806 (CRL-2335, ATCC, Manassas, VA, USA) was cultured in RPMI medium (R7509-500ML, Sigma-Aldrich, St. Louis, MO, USA) containing 10% FCS, L-glutamine and penicillin/streptomycin.

    Techniques: Proliferation Assay, Control, Knock-Out

    Relative adhesion of PCDHGC3 knockout breast cancer and melanoma cells to human in vitro BBB models. Adhesion measurements of HCC1806 PCDHGC3 knockout (KO) and control cells to hCMEC/D3 ( a ) and BLECs ( b ) after 30, 60, and 120 min. Adhesion measurements of A2058 PCDHGC3 knockout (KO) and control cells to hCMEC/D3 ( c ) and BLECs ( d ) after 30, 60, and 120 min. Control cell adhesion was measured at each time point; however, for clarity, only the measurement after 30 min is shown. Data are presented as mean relative adhesion versus control with standard deviation, **** = p ≤ 0.0001, one-way ANOVA test.

    Journal: NeuroSci

    Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells

    doi: 10.3390/neurosci7020047

    Figure Lengend Snippet: Relative adhesion of PCDHGC3 knockout breast cancer and melanoma cells to human in vitro BBB models. Adhesion measurements of HCC1806 PCDHGC3 knockout (KO) and control cells to hCMEC/D3 ( a ) and BLECs ( b ) after 30, 60, and 120 min. Adhesion measurements of A2058 PCDHGC3 knockout (KO) and control cells to hCMEC/D3 ( c ) and BLECs ( d ) after 30, 60, and 120 min. Control cell adhesion was measured at each time point; however, for clarity, only the measurement after 30 min is shown. Data are presented as mean relative adhesion versus control with standard deviation, **** = p ≤ 0.0001, one-way ANOVA test.

    Article Snippet: Triple-negative breast cancer cell line HCC1806 (CRL-2335, ATCC, Manassas, VA, USA) was cultured in RPMI medium (R7509-500ML, Sigma-Aldrich, St. Louis, MO, USA) containing 10% FCS, L-glutamine and penicillin/streptomycin.

    Techniques: Knock-Out, In Vitro, Control, Standard Deviation

    PCDHGC3 KO leads to stronger invasion of PCDHGC3 knockout breast cancer and melanoma cells. HCC1806 PCDHGC3 knockout (KO) and control cells ( a ) and A2058 PCDHGC3 knockout (KO) and control ( b ) invaded for 48 h through Transwells coated with Matrigel. The number of invaded cells is shown. Data are presented as mean cell number with standard deviation, * = p ≤ 0.05, unpaired t -test.

    Journal: NeuroSci

    Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells

    doi: 10.3390/neurosci7020047

    Figure Lengend Snippet: PCDHGC3 KO leads to stronger invasion of PCDHGC3 knockout breast cancer and melanoma cells. HCC1806 PCDHGC3 knockout (KO) and control cells ( a ) and A2058 PCDHGC3 knockout (KO) and control ( b ) invaded for 48 h through Transwells coated with Matrigel. The number of invaded cells is shown. Data are presented as mean cell number with standard deviation, * = p ≤ 0.05, unpaired t -test.

    Article Snippet: Triple-negative breast cancer cell line HCC1806 (CRL-2335, ATCC, Manassas, VA, USA) was cultured in RPMI medium (R7509-500ML, Sigma-Aldrich, St. Louis, MO, USA) containing 10% FCS, L-glutamine and penicillin/streptomycin.

    Techniques: Knock-Out, Control, Standard Deviation

    Relative expression of target genes in PCDHGC3 KO breast cancer and melanoma cells. The relative expression (RQ value) of each target in PCDHGC3 KO HCC1806 ( a ) and PCDHGC3 KO A2058 ( b ) cells relative to control cells is shown. A RQ value < 1.0 indicates decreased expression, a RQ value > 1.0 indicates increased expression compared to the control cells. The means with standard deviation are shown as the fold of the control. * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001, **** = p ≤ 0.0001, unpaired t -test.

    Journal: NeuroSci

    Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells

    doi: 10.3390/neurosci7020047

    Figure Lengend Snippet: Relative expression of target genes in PCDHGC3 KO breast cancer and melanoma cells. The relative expression (RQ value) of each target in PCDHGC3 KO HCC1806 ( a ) and PCDHGC3 KO A2058 ( b ) cells relative to control cells is shown. A RQ value < 1.0 indicates decreased expression, a RQ value > 1.0 indicates increased expression compared to the control cells. The means with standard deviation are shown as the fold of the control. * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001, **** = p ≤ 0.0001, unpaired t -test.

    Article Snippet: Triple-negative breast cancer cell line HCC1806 (CRL-2335, ATCC, Manassas, VA, USA) was cultured in RPMI medium (R7509-500ML, Sigma-Aldrich, St. Louis, MO, USA) containing 10% FCS, L-glutamine and penicillin/streptomycin.

    Techniques: Expressing, Control, Standard Deviation

    Matrix metalloproteinase (MMP) activity in cell culture medium of PCDHGC3 knockout (KO) breast cancer and melanoma cells. Fluorescence signal of MMP-substrate (SB) cleavage in the cell culture medium of PCDHGC3 KO HCC1806 ( a ) and PCDHGC3 KO A2058 ( b ) cells and control cells is expressed as relative fluorescence units (RFU) ± standard deviation. ** = p < 0.01, *** = p < 0.001, unpaired t test.

    Journal: NeuroSci

    Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells

    doi: 10.3390/neurosci7020047

    Figure Lengend Snippet: Matrix metalloproteinase (MMP) activity in cell culture medium of PCDHGC3 knockout (KO) breast cancer and melanoma cells. Fluorescence signal of MMP-substrate (SB) cleavage in the cell culture medium of PCDHGC3 KO HCC1806 ( a ) and PCDHGC3 KO A2058 ( b ) cells and control cells is expressed as relative fluorescence units (RFU) ± standard deviation. ** = p < 0.01, *** = p < 0.001, unpaired t test.

    Article Snippet: Triple-negative breast cancer cell line HCC1806 (CRL-2335, ATCC, Manassas, VA, USA) was cultured in RPMI medium (R7509-500ML, Sigma-Aldrich, St. Louis, MO, USA) containing 10% FCS, L-glutamine and penicillin/streptomycin.

    Techniques: Activity Assay, Cell Culture, Knock-Out, Fluorescence, Control, Standard Deviation